SPIRAMYCIN

Background and Date of Approval

Spiramycin received orphan drug designation from the FDA on October 17, 1984, for treatment of chronic cryptosporidiosis in immunodeficient patients, with the aim of providing symptomatic relief and parasitic cure. However, Spiramycin has not received FDA approval for this specific orphan indication.

Uses

Spiramycin treats respiratory tract infections like pharyngitis, tonsillitis, and bronchitis, as well as skin and soft tissue infections such as cellulitis and impetigo. Doctors also use it to treat toxoplasmosis, especially in pregnant women, to reduce the risk of fetal transmission. Additionally, healthcare providers prescribe Spiramycin for dental infections and, under its orphan drug designation, to manage chronic cryptosporidiosis in immunocompromised patients, such as those with HIV/AIDS, though it is not FDA-approved for this use.

How is it administered?

Doctors usually administer Spiramycin orally in tablet or suspension form, with doses ranging from 1 to 3 grams per day, divided into multiple doses. For severe infections, healthcare providers may give it intravenously in a hospital setting. Patients should always follow their healthcare provider's instructions and not crush or chew the tablets; they should swallow them whole to ensure proper absorption. The treatment duration depends on the infection, typically lasting 7 to 14 days for respiratory infections or longer for conditions like toxoplasmosis. A healthcare provider should determine the exact dosing regimen.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Common side effects of Spiramycin: Nausea Vomiting Diarrhea Abdominal pain or discomfort Loss of appetite Headache Rare side effects of Spiramycin: Allergic reactions (e.g., rash, itching, swelling) Liver problems (e.g., jaundice, elevated liver enzymes) Hearing loss or ringing in the ears (tinnitus) Severe diarrhoea (potentially Clostridium difficile infection) Blood disorders (e.g., low white blood cell count, thrombocytopenia) Interstitial lung disease or respiratory issues (rarely)

Warnings

Allergic Reactions: May cause serious allergic reactions, including anaphylaxis, particularly in individuals with a history of hypersensitivity to macrolide antibiotics. Liver Impairment: Caution is advised in patients with liver disease, as Spiramycin may cause liver toxicity. Regular monitoring of liver function is recommended during treatment. Gastrointestinal Issues: This may cause severe diarrhoea, which could be a sign of Clostridium difficile infection. If severe diarrhoea occurs, stop the medication and seek medical attention. QT Prolongation: Like other macrolides, Spiramycin may prolong the QT interval, potentially leading to serious arrhythmias, especially in patients with pre-existing heart conditions. Hearing Impairment: High doses or prolonged use may cause ototoxicity, leading to hearing loss or tinnitus. Monitor patients on long-term therapy for auditory changes. Pregnancy Category: Spiramycin should be used in pregnancy only if clearly needed, especially during the first trimester, due to potential risks to the fetus. Drug Interactions: Spiramycin may interact with other medications, particularly those that affect the liver's cytochrome P450 system, leading to altered drug levels or side effects.

Precautions

Before using Spiramycin, patients should inform their healthcare provider about any liver disease, kidney issues, or allergies to macrolide antibiotics. Doctors should use caution when prescribing Spiramycin to patients with a history of QT prolongation or heart conditions, as it may affect heart rhythm. Pregnant or breastfeeding women should use Spiramycin only if absolutely necessary, as its safety in these populations hasn't been fully established. Patients should disclose all other medications they are taking to avoid potential drug interactions. Healthcare providers should monitor liver function during treatment, and patients should watch for gastrointestinal disturbances like diarrhoea or signs of allergic reactions.

Word of Advice

Take Spiramycin precisely as prescribed by your healthcare provider. Do not omit doses or discontinue the medication early, even if symptoms improve, as this may result in incomplete treatment and recurrence of infection. If you miss a dose, take it as soon as you recall, but skip it if your next dose is nearly due. Never take two doses together. Swallow tablets whole; do not crush or chew them. If you develop severe diarrhoea, skin rashes, or signs of allergic reaction, contact your doctor immediately. Inform your healthcare provider of all other medications you are taking to prevent interactions. If you are pregnant, planning pregnancy, or breastfeeding, discuss with your doctor to assess the risks and benefits of Spiramycin use.

References

https://pubchem.ncbi.nlm.nih.gov/compound/Spiramycin https://pubmed.ncbi.nlm.nih.gov/9571302/ Montoya, J.G., Laessig, K., Fazeli, M.S. et al. A fresh look at the role of spiramycin in preventing a neglected disease: meta-analyses of observational studies. https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-021-00606-7

Frequently Asked Questions

Is Spiramycin used in pregnancy?

Spiramycin is generally considered safe to use during pregnancy, particularly in the second and third trimesters, for treating toxoplasmosis. However, doctors only recommend it if the benefits outweigh the risks, especially during the first trimester. Always consult your healthcare provider before using Spiramycin during pregnancy.

Should Spiramycin be taken before or after food?

Spiramycin can be taken with or without food. There is no specific requirement regarding meals, but taking it with food may help reduce any potential stomach upset. Always follow your healthcare provider's instructions for the best results.

How long to take spiramycin?

The duration of Spiramycin treatment depends on the infection being treated, typically ranging from 7 to 14 days. Always follow healthcare provider instructions for the correct length of treatment to ensure effectiveness and reduce the risk of resistance.

What drug group is Spiramycin?

Spiramycin belongs to the macrolide class of antibiotics. This group works by inhibiting bacterial protein synthesis, which helps to stop the growth of bacteria. Macrolides, including Spiramycin, are effective against a range of gram-positive bacteria and certain atypical pathogens.

Is spiramycin a macrolide?

Yes, Spiramycin is a macrolide antibiotic. It works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and treating infections caused by susceptible organisms.

Available Brands 1

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS